The ligation of PD-1 and PD-L1 or PD-L2 on tumor cells or antigen-presenting cells (APCs) elicits an immunosuppressive response, which implements subsequent metabolic reprogramming in T cells, decreases effector T cells and memory T cells, and increases Treg and exhausted T cell abundance (10). This evidence concerns the gene CD274 and neoplasm.